Breaking News

Tweet TWEET

Orthofix International Announces Reappointment of Maria Sainz to Board of Directors

  Orthofix International Announces Reappointment of Maria Sainz to Board of
  Directors

Business Wire

LEWISVILLE, Texas -- November 28, 2012

Orthofix International N.V., (NASDAQ:OFIX) (the Company) announced today the
reappointment of Maria Sainz to its Board of Directors. Ms. Sainz, formerly
the Chief Executive Officer of Concentric Medical, Inc. (“Concentric”),
resigned from the Company’s Board in September 2011 as the result of a
potential conflict of interest arising from an announced acquisition of
Concentric. Ms. Sainz had been a member of the Company’s Board of Directors
since 2008. Ms. Sainz is currently serving as the President, Chief Executive
Officer, and Director of CardioKinetix Inc., a medical device company located
in Menlo Park, California.

“We are delighted to have Maria rejoining us,” said James F. Gero, Chairman of
the Board of Directors. “Maria provides the Orthofix Board with significant
experience in the medical device industry, as well as insight into
international markets. The fact that she previously served on our Board will
help provide an immediate positive contribution.”

“Orthofix is approaching the next chapter in its evolution as it utilizes its
high profitability and financial capacity to drive revenue growth and maximize
shareholder value,” commented Robert Vaters, President and Chief Executive
Officer. “Maria’s experience and perspective as a medical device chief
executive officer will strongly contribute in achieving this.”

Ms. Sainz has over 20 years of experience in the medical device industry
having held commercial and general management positions in the US and Europe
with small companies and large corporations. Ms. Sainz served as the President
and CEO of Concentric Medical, Inc. since April 2008. In October 2011,
Concentric Medical was acquired by Stryker Corporation where she was named
General Manager of the business unit of Stryker Neurovascular, where she
served until May 2012. From 2006 to 2008, Maria led integration activities
following the acquisition of Guidant by Boston Scientific. From February 2003
through July 2006, Ms. Sainz served as President of the Cardiac Surgery
division of Guidant Corporation/Boston Scientific. From January 2001 through
February 2003, Ms. Sainz served as Vice President, Global Marketing for the
Vascular Intervention division of Guidant Corporation. From late 1998 through
early 2001, Ms. Sainz served as Vice President of the Intermedics Cardiac
Rhythm Management business of Guidant Corporation in Europe. Prior to that Ms.
Sainz held several sales and marketing assignments of increasing
responsibility in Guidant’s European operations. Ms. Sainz received an M.A. in
Languages from the University Complutense in Madrid, Spain and a Masters in
International Management from the American Graduate School of International
Management.

About Orthofix:

Orthofix International N.V. is a diversified, global medical device company
focused on developing and delivering innovative repair and regenerative
solutions to the spine and orthopedic markets. Orthofix’s products are widely
distributed around the world to orthopedic surgeons and patients via
Orthofix’s sales representatives and its subsidiaries, and via collaborations
with other leading orthopedic product companies. In addition, Orthofix is
collaborating on R&D activities with leading research and clinical
organizations such as the Musculoskeletal Transplant Foundation, the
Orthopedic Research and Education Foundation, and Texas Scottish Rite Hospital
for Children. For more information about Orthofix, please visit
www.orthofix.com.

Contact:

Orthofix International N.V.
Mark Quick, 214-937-2924
Director of Investor Relations and Business Development
markquick@orthofix.com